Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 26.14% ano a ano.
Avaliação Justa
O PE mais recente da empresa é -26.04, em uma faixa percentil média de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 12.64M ações, uma redução de 24.17% em relação ao trimestre anterior.
Mantido por The Vanguard
O Super Investidor The Vanguard possui 810.18K ações desta empresa.
Alta Atividade de Mercado
A empresa tem maior interesse dos investidores, com uma taxa de giro de 20 dias de 0.62.